Comparison of pharmacodynamic variables following oral versus transdermal administration of atenolol to healthy cats

American Journal of Veterinary Research

Volumn 69, Issue 1, 2008, Pages 39-44

  MacGregor, John M ^a,d   Rush, John E ^a   Rozanski, Elizabeth A ^a   Boothe, Dawn M ^b   Belmonte, Albert A ^c   Freeman, Lisa M ^a  

^a TUFTS UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

^c MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^d Animal Medical Center of New England   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CAT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG DISPOSITION; ELECTROCARDIOGRAM; GEL; HEART RATE; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; TABLET;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANIMALS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; CATS; HEALTH; MALE;

ANIMALIA;

EID: 38749145912     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.1.39     Document Type: Article

References (34)

1. Rush JE, Freeman LM, Fenollosa NK, et al. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999). J Am Vet Med Assoc 2002;220:202-207.
2. Harpster NK. The cardiovascular system. In: Holzworth J, ed. Diseases of the cat. Philadelphia: WB Saunders Co, 1986;820-953.
3. Fox PR. Feline cardiomyopathies. In: Fox PR, Sisson D, Moise NS, eds. Textbook of canine and feline cardiology: principles and clinical practice. Philadelphia: WB Saunders Co, 1999;621-678.
4. Rodriguez DB, Harpster N. Treatment of feline cardiomyopathy. Compendium 2002;24:470-476.
5. Fox PR. Evidence for and against beta blockers and aspirin for management of feline cardiomyopathies. Vet Clin North Am Small Anim Pract 1991;21:1011-1022.
6. Rush JE. Therapy of feline hypertrophic cardiomyopathy. Vet Clin North Am 1998;28:1459-1479.
7. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-1355.
8. RESOLVD Investigators. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy. The randomized evaluation of strategies for left ventricular dysfunction pilot study. Circulation 2000;101:378-384.
9. Pfisterer M, Cox JL, Granger CB, et al. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction; the GUSTO-I experience. Global utilization of streptokinase and TPA (alteplase) for occluded coronary arteries. J Am Coll Cardiol 1998;32:634-640.
10. Spirito P, Siedman CE, McKenna WJ, et al. The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775-785.
11. Louie EK, Edwards LC III. Hypertrophic cardiomyopathy. Prog Cardiovasc Dis 1994;36:275-308.
12. Kittleson MD. Hypertrophic cardiomyopathy In: Kittleson MD, Kienle RD, eds. Small animal cardiovascular medicine. St Louis: Mosby, 1998;347-362.
13. Quinones M, Dyer DC, Ware WA, et al. Pharmacokinetics of atenolol in clinically normal cats. Am J Vet Res 1996;57:1050-1053.
14. Hoffman SB, Yoder AR, Trepanier LA. Bioavailability of transdermal methimazole in a pluronic Lecithin organogel (PLO) in healthy cats. J Vet Pharmacol Ther 2002;25:189-193.
15. Magnusson BM, Walters KA, Roberts MS. Veterinary drug delivery: potential for skin penetration enhancement. Adv Drug Deliv Rev 2001;50:205-227.
16. Naik A, Yogeshvar YN, Guy RH. Transdermal drug delivery: overcoming the skin's barrier function. Pharm Sci Tech 2000;3:318-326.
17. Kalia YN, Merino V, Guy RH. Transdermal drug delivery: clinical aspects. Dermacol Clin 1998;16:289-299.
18. Parameswaran N, Hamlin RL, Nakayama T, et al. Increased splenic capacity in response to transdermal application of nitroglycerin in the dog. J Vet Intern Med 1999;13:44-46.
19. Gelasch KL, Kruse-Elliot KT, Osmond CS, et al. Comparison of transdermal fentanyl versus intramuscular administration of butorphanol for analgesia after onychectomy in cats. J Am Vet Med Assoc 2002;220:1020-1024.
20. Kyles AE, Papich M, Hardie E. Disposition of transdermally administered fentanyl in dogs. Am J Vet Res 1996;57: 715-719.
21. Fransson BA, Peck KE, Smith JK, et al. Transdermal absorption of a liposome-encapsulated formulation of lidocaine following topical administration in cats. Am J Vet Res 2002;63: 1309-1312.
22. Hoffmann G, Marks SL, Taboada J, et al. Transdermal methimazole treatment in cats with hyperthyroidism. J Feline Med Surg 2003;5:77-82.
23. Jain GK, Kaul JL, Agrawal SS. In vitro transdermal delivery of atenolol using mouse and guinea pig. Indian J Exp Biol 1993;31:691-693.
24. Demou JS, Sidhom MB, Plakogiannnis FM. Comparative in vitro diffusion studies for atenolol transdermal delivery system. Pharm Acta Helv 1994;68:215-219.
25. Kobayashi I, Hosaka K, Ueno T, et al. Relationship between amount of beta-blockers permeating through the stratum corneum and skin irritation after application of beta-blocker adhesive patches to guinea pig skin. Biol Pharm Bull 1997;20:421-427.
26. Belew AM, Barlett T, Brown SA. Evaluation of the White-coat effect in cats. J Vet Intern Med 1999;13:134-142.
27. Fox PR, Liu S-K, Maron BJ. Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy: an animal model of human disease. Circulation 1995;92:2645-2651.
28. Brown DJ, Rush JE, MacGregor JM, et al. M-mode echocardiographic ratio indices in normal dogs, cats, and horses: a novel quantitative method. J Vet Intern Med 2003;17:653-662.
29. Atkins CE, Gallo AM, Kurzman ID, et al. Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985-1989). J Am Vet Med Assoc 1992;201:613-618.
30. Finnin BC, Morgan TM. Transdermal penetration enhancers: applications, limitations and potential. J Pharmacol Sci 1999;88:955-958.
31. Hadgraft J, Pugh WJ. The selection and design of topical and transdermal agents: a review. J Investig Dermatol Symp Proc 1998;3:131-135.
32. Berti JJ, Lipsky JJ. Transcutaneous drug delivery: a practical review. Mayo Clin Proc 1995;70:581-586.
33. Sartor LL, Trepanier LA, Kroll MM, et al. Efficacy and safety of transdermal methimazole in the treatment of cats with hyperthyroidism. J Vet Intern Med 2004;18:651-655.
34. Williman H, Walde P, Luisi PL, et al. Lecithin organogel as matrix for transdermal transport of drugs. J Pharmacol Sci 1992;81:871-875.